Media

BIO Latin American Conference will bring together biotechnology executives, academics and investors from around the globe
Registration for this year’s Livestock Biotech Summit is officially open to attendees and credentialed media, the Biotechnology Industry Organization (...

Press Releases

Mar 22 2001
The Biotechnology Industry Organization ("BIO") is pleased to have the opportunity to submit testimony expressing our concerns about the federal...
Mar 13 2001
Reporters urged to register now! WASHINGTON, D.C. (March 13, 2001) – The Biotechnology Industry Organization (BIO) today announced that the preliminary program...
Mar 7 2001
WASHINGTON, D.C. (March 7, 2001) -- The Biotechnology Industry Organization (BIO) today issued the following statement following the Environmental Protection...
Mar 6 2001
Washington, D.C. (March 6, 2001) -- The Biotechnology Industry Organization (BIO) today issued the following statement following Senate introduction of a bill...
Mar 1 2001
Washington, D.C. (March 1, 2001) -- The Biotechnology Industry Organization (BIO) will begin a six month television advertising campaign this weekend on both...
Feb 22 2001
WASHINGTON, DC (February 22, 2001) --Michael J. Werner, director of federal government relations and bioethics counsel for the Biotechnology Industry...
Feb 16 2001
Washington, D.C. – A record 32 biotechnology drugs, vaccines and new indications for existing medicines were approved by the U.S. Food and Drug Administration...
Feb 15 2001
WASHINGTON, D.C. (February 15, 2001) -- Carl B. Feldbaum,president of the Biotechnology Industry Organization (BIO), issued the following statement today on...
Feb 14 2001
WASHINGTON, D.C. (February 14, 2001) – U.S. Sen. Tim Hutchinson (R-Arkansas) and Newt Gingrich, former Speaker of the U.S. House of Representatives, will be...


Biotechnology News

April 18, 2014

WATERTOWN, Mass.--(BUSINESS WIRE)--Dicerna Pharmaceuticals, Inc. (NASDAQ: DRNA), a leader in the development of RNAi-based therapeutics, today announced that it granted...

April 18, 2014

NEW YORK--(BUSINESS WIRE)--Pfizer Inc. invites investors and the general public to listen to a webcast of the Annual Meeting of Shareholders at 8:30 a.m. (Eastern Daylight...

April 18, 2014

LEXINGTON, Mass.--(BUSINESS WIRE)--Cubist Pharmaceuticals Issues Voluntary Nationwide Recall of One Lot of CUBICIN (daptomycin for injection) 500 mg in 10 mL single use...

April 18, 2014

WASHINGTON--(BUSINESS WIRE)--Pioneers in Regenerative Therapy to Discuss New Trends in Stem Cell Medicine; International leaders to share unparalleled achievements in stem...

April 18, 2014

GEORGETOWN, Texas--(BUSINESS WIRE)--Molecular Templates, Inc., a biopharmaceutical company focused on the discovery and development of a new class of biologic therapies...